Correlation Between Acrivon Therapeutics, and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Century Therapeutics, you can compare the effects of market volatilities on Acrivon Therapeutics, and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Century Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Century Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Acrivon and Century is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Century Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Century Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.65 times more return on investment than Century Therapeutics. However, Acrivon Therapeutics, Common is 1.54 times less risky than Century Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Century Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 627.00 in Acrivon Therapeutics, Common on September 19, 2024 and sell it today you would earn a total of 94.00 from holding Acrivon Therapeutics, Common or generate 14.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Century Therapeutics
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Century Therapeutics |
Acrivon Therapeutics, and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Century Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |